Tuesday, November 5, 2019

FW: (LML) Infolep monthly overview of new publications on leprosy - November 2019

 

Leprosy Mailing List – November 5,  2019

Ref.:    (LML) Infolep monthly overview of new publications on leprosy - November 2019

From:  Jiske Erlings, Amsterdam, the Netherlands


Dear Pieter and colleagues,


Every month we send you an overview of (scientific) publications on leprosy recently added to the Infolep website. To search the full collection, please visit www.leprosy-information.org.


Feel free to contact me to receive the full-text versions if a link to the full text is not included or for assistance with your literature research. You are also invited to send us your publications on leprosy for inclusion in the portal.

With warm regards,

Jiske Erlings

Infolep Coordinator & Information Officer
j.erlings@infolep.org

 


 

Highlighted publications

 


 

The Zero Leprosy Toolkit - set of field-tested best practices designed to support countries in their work towards ending leprosy and its associated dissabilies and stigma.
GPZL. 2019. https://zeroleprosy.org/toolkit/
 

 


 

New publications

 


 

Unanswered questions on the safety of MDT-U.
Barve A. An Bras Dermatol. 2019 Oct 17;94(4):499.
Download PDF


Unanswered questions on the safety of MDT-U - Reply.
Penna GO, Gonçalves HS, Pontes MAA. An Bras Dermatol. 2019 Oct 17;94(4):500.
Download PDF

 


16S rDNA based skin microbiome data of healthy individuals and leprosy patients from India.
Bayal N, Nagpal S, Haque MM, et al. Sci Data. 2019 Oct 22;6(1):225. 
Download PDF
 


Investigating a possible linkage of working with migrant workers and new leprosy cases among indigenous populations of Shimla, Himachal Pradesh, India.
Bharti OK, Rana RS, Kaushal DS. Indian J Lepr. 2019.
Download PDF
 


Lepromatous leprosy, melanoma, and basal cell carcinoma: clinical-histopathologic association.
Braghiroli CS, Parise-Fortes MR, Alencar Marques ME, et al. Anais Brasileiros de Dermatologia, 2019. 
Download PDF
 


Lepromatous reaction type II: Clinical and laboratory aspects. 
Carneiro S, Nakasato FK, Balassiano V, et al. Skinmed. 2019 Jul 1;17(4):261-265. eCollection 2019.
Read more
 


Develop and field evolution of single tube nested PCR, SYBRGreen PCR methods, for the diagnosis of leprosy in paraffin-embedded formalin fixed tissues in Yunnan Province, a hyper endemic area of leprosy in China.
Chen X, Xing Y, He J, et al. PLoS Negl Trop Dis. 2019 Oct 2;13(10):e0007731. 
Download PDF
 


Molecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients.
Chokkakula S, Chen Z, Wang L, et al. Emerg Microbes Infect. 2019;8(1):1479-1489.
Download PDF
 


Leprosy: prevalence and factors associated with seropositivity for anti-NDO-LID antibodies in children under 15 years of age.
Gomes LC, Cortela DDCB, Silva EA, et al. An Bras Dermatol. 2019 Oct 17;94(4):405-410.
Download PDF
 


Scientific evidence on leg ulcers as leprosy sequel.
Guimarães HC, Pena SB, Lopes JL, et al. Acta Paul Enferm. 2019;32(5):564-70.
Download PDF
 


The burden leprosy diseases in India: A study with special reference to Tamilnadu and their districts.
Hariharan. R. Int J Res Engin, IT Soc Sci. 2019.
Download PDF
 


Post kala azar dermal leishmaniasis and leprosy prevalence and distribution in the Muzaffarpur health and demographic surveillance site.
Hasker E, Malaviya P, Scholar VK, et al.PLoS Negl Trop Dis. 2019 Oct 25;13(10):e0007798.
Download PDF
 


Evaluation of antibody detection against the NDO-BSA, LID-1 and NDO-LID antigens as confirmatory tests to support the diagnosis of leprosy in Yunnan province, southwest China.
Jian L, Xiujian S, Yuangang Y, et al. Trans R Soc Trop Med Hyg. 2019 Oct 31.
Read more
 


Tuberculosis treatment unmasking leprosy: management of drug-resistant tuberculosis and leprosy co-infection.
Kama G, Huang GKL, Taune M, et al. Public Health Action. 2019 Sep 21;9(Suppl 1):S83-S85.
Read more
 


[Maxillary bone deformation in patients with leprosy: a novel method for quantitative evaluation by CT scan.] 
Kasai N. Jap J Leprosy. 2019. Japanese.
Download 
 


Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines.
Lockwood DNJ, Lambert S, Srikantam A, et al. PLoS Negl Trop Dis. 2019 Oct 31;13(10):e0007671.
Download PDF
 


Trends of leprosy and multibacillary infection in the state of Georgia since the early 1900s.
McCormick CD, Lea J, Stryjewska BM, Thompson A, Fairley JK. PLoS Negl Trop Dis. 2019 Oct 11;13(10):e0007713.
Download PDF
 


Myelin breakdown favors Mycobacterium leprae survival in Schwann cells.
Mietto BS, de Souza BJ, Pessolani MCV, et al. Cell Microbiol. 2019 Oct 25:e13128
Read more
 


[A study on the entering and out-going trends at Japan's National Hansen's Disease sanatoriums.]
Mori S, Ato M, Ishii N. Jap J of Leprosy. 2019. Japanese.
Download PDF
 


Identification and validation of host biomarkers for leprosy: A step forward to establish point-of-care tests.
Nausch N, Jacobsen M. EBioMedicine. 2019 Oct 17.
Download PDF
 


Vitamin D receptor gene polymorphisms are associated with leprosy in Southern Brazil.
Pepineli AC, Alves HV, Tiyo BT, et al. Front Immunol. 2019 Oct 4;10:2157.
Download PDF
 


Indonesians Human Leukocyte Antigen (HLA) distributions and correlations with global diseases. Pradana KA, Widjaya MA, Wahjudi M. Immunol Invest. 2019 Oct 24:1-31.
Read more
 


Changes in social participation of persons affected by leprosy, before and after multidrug therapy, in an endemic state in Eastern India.
Ramasamy S, Govindharaj P, Kumar A, et al. DCID. 2019. 
Download PDF
 


Sobreposição de casos novos de hanseníase em redes de convívio domiciliar em dois municípios do Norte e Nordeste do Brasil, 2001-2014 / Overlapping of new leprosy cases in household contact networks in two municipalities in North and Northeast Brazil, 2001-2014. 
Reis ADSD, Souza EA, Ferreira AF, et al. Cad Saude Publica. 2019 Oct 7;35(10):e00014419.
Download PDF
 


A distinct double positive IL-17A(+)/F(+) T helper 17 cells induced inflammation leads to IL17
producing neutrophils in Type 1 reaction of leprosy patients.

Saini C, Srivastava RK, Kumar P, et al. Cytokine. 2019 Oct 16;126:154873.
Read more
 


Anterior tarsal tunnel syndrome: an atypical involvement in primary neural leprosy.
Santos DFD, Pereira RC, Goulart IMB. Arq Neuropsiquiatr. 2019 Oct 24;77(10):754-755.
Download PDF
 


Lipoarabinomannan from Mycobacterium indicus pranii shows immunostimulatory activity and induces
autophagy in macrophages.

Singh B, Saqib M, Chakraborty A, Bhaskar S. PLoS One. 2019 Oct 24;14(10):e0224239.
Download PDF
 


Trend of leprosy detection rate in Brazil, 1990 to 2016.
de Souza CDF, Santos FGG, Leal TC, et al. Anais Brasileiros de Dermatologia, 2019.
Download PDF
 


Identification of a systemic interferon-γ inducible antimicrobial gene signature in leprosy patients
undergoing reversal reaction.

Teles RMB, Lu J, Tió-Coma M, et al. PLoS Negl Trop Dis. 2019 Oct 10;13(10):e0007764.
Download PDF
 


A double blow for a patient with leprosy: a reversal reaction and an adverse drug reaction.
Thangaraju P, Venkatesan S. Lancet. 2019 Oct 19;394(10207):1450.
Download PDF
 


New therapeutics for leprosy.
Walker SL. Br J Dermatol. 2019 Oct 16.
Read more
 


[Investigation of CTLA-4 +49 A/G gene polymorphism in the Leprosy patients and their effects on type and severity of disease].
Yeghaneh Kh, Naghili B, Babalou Z, Ail Paristy M R. Med J Tabriz Uni Med Sciences Health Services. 2019 October- November; 41(4):101-109. Persian.
Download PDF
 

 


 

 


 

Journals & Newsletters

 


 

Disability, CBR & Inclusive Development: http://dcidj.org/

Hansenologia Internationalis: http://www.ilsl.br/revista/atual.php

Indian Journal of Leprosy: http://www.ijl.org.in/index.html

Japanese Journal of Leprosy:
https://www.jstage.jst.go.jp/browse/hansen/88/2/_contents/-char/en

Leprosy Review: https://www.lepra.org.uk/leprosy-review
Leprosy Review Repository (1928-2001): http://leprev.ilsl.br/arquivo.php

Plos Neglected Tropical Diseases: http://journals.plos.org/plosntds/

Revista de Leprología:
http://www.leprosy-information.org/resource/revista-de-leprologia

WHO Goodwill Ambassador's Newsletter for the elimination of leprosy:
https://www.shf.or.jp/information/g/ambassador?lang=en

 


 

Websites & Services

 


 

WHO Global Leprosy Programme
http://www.who.int/lep/en/ &
http://www.searo.who.int/entity/global_leprosy_programme/en/

The Global Partnership for Zero leprosy
http://zeroleprosy.org/

LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in this theme to share ideas, information, experiences and questions.
https://groups.google.com/forum/#!forum/leprosymailinglist

Fontilles y la lepra en España / Fontilles and leprosy in Spain
http://www.cervantesvirtual.com/portales/fontilles_y_la_lepra_en_espana/

InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)
https://www.infontd.org/



 


 

GDPR & the Infolep newsletter

 


 

New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regard to the GDPR, including our privacy statement and mailing list. Infolep sends out monthly e-mails to its subscribers with an overview of recent publications on leprosy. The purpose of this activity is to keep subscribers up to date. Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else. We hope the content from the Infolep newsletter is useful to you, but you can update your preferences.


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/544bc4a7-62b6-4b57-a827-00093bfac37f%40googlegroups.com.

No comments: